Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults

Cited by (277)

Items 201–277 of 277

1. Association between bone mineral density and coronary plaque burden in patients with coronary artery disease: a cross-sectional study using quantitative computed tomography
   Guang Geng, Zhen Li, Shuai Wang, Tao Yuan, Guanmin Quan · 2023 · Coronary Artery Disease
2. Circulating sclerostin levels in relation to nutritional status, sex hormones and selected bone turnover biochemical markers levels in peri- and postmenopausal women
   Mariola Czajkowska, Ryszard Plinta, Aleksander Jerzy Owczarek, Magdalena Olszanecka‐Glinianowicz, Violetta Skrzypulec‐Plinta · 2019 · Ginekologia Polska
3. Development of a Smartphone Application for Promoting Bone Health in Korean Young Adult Women: A Pilot Study
   Young-Joo Park, Sook-Ja Lee, Nah-Mee Shin, Hyunjeong Shin, Sung‐Jin Yoon, Songi Jeon, Inhae Cho · 2015 · Korean Journal of Adult Nursing
4. Study of serum sclerostin levels in association to entheseal ultrasonography in Egyptian psoriatic arthritis patients
   El-Attar A. M. Enas, Dina A. Farrag, El-Mallah E. Reem, Dalia Youssef Samaha · 2017 · Egyptian Rheumatology and Rehabilitation
5. The Relationship between Sclerostin and Kidney Transplantation Mineral Bone Disorders: A Molecule of Controversies
   Barış Afşar, Rengin Elsürer Afşar, Yaşar Çalışkan, Krista L. Lentine · 2024 · Calcified Tissue International
6. Role of sclerostin in mastocytosis bone disease
   Aneta Szudy‐Szczyrek, Radosław Mlak, Dominika Pigoń-Zając, Witold Krupski, Marcin Mazurek, Aleksandra Tomczak, Karolina Chromik, Aleksandra Górska, Paweł Koźlik, Adrian Juda et al. · 2025 · Scientific Reports
7. The effect of regular fitness training, sex hormones, and turnover of selected bone markers on sclerostin levels in young women
   Ryszard Plinta, Mariola Czajkowska, Magdalena Pisula, Anna Brzęk, Andrzej Knapik, Magdalena Olszanecka‐Glinianowicz, Violetta Skrzypulec‐Plinta · 2020 · Archives of Medical Science
8. Bone and fat hormonal crosstalk with antiretroviral initiation
   Arnold Z. Olali, Qiuhu Shi, Donald R. Hoover, Mariana Bucovsky, Elizabeth J. Shane, Michael T. Yin, Ryan D. Ross · 2021 · Bone
9. Sclerostin level in rheumatoid arthritis patients and its relationship to disease severity and bone mineral density
   AbdelGhani Eman, AbdelMegid Mona, Barakat Barakat, Ayad Mona, Bakri Heba · 2018 · Egyptian Journal of Obesity Diabetes and Endocrinology
10. Serum sclerostin levels in renal cell carcinoma patients with bone metastases
    Christine Wibmer, Karin Amrein, Astrid Fahrleitner‐Pammer, Magdalena Maria Gilg, Andrea Berghold, Georg C. Hutterer, Werner Maurer-Ertl, Armin Gerger, Andreas Leithner, Martin Pichler et al. · 2016 · Scientific Reports
11. Disorders of calcium and phosphorus homeostasis in the newborn and infant
    Allen W. Root · 2014 · Elsevier eBooks
12. Effect of adrenocorticotropic hormone infusion on circulating sclerostin levels
    Sarah Zaheer, Kayla Meyer, Rebecca Easly, Omar Bayomy, Janet Leung, Andrew W Koefoed, Mahyar Heydarpour, Roy Freeman, Gail Kurr Adler · 2021 · Endocrine Connections
13. Urinary Calcium Is Associated with Serum Sclerostin among Stone Formers
    Fernanda Guedes Rodrigues, Milene Subtil Ormanji, Igor Gouveia Pietrobom, Ana Cristina Carvalho de Matos, Martin H. de Borst, Ita Pfeferman Heilberg · 2023 · Journal of Clinical Medicine
14. Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis
    Wei Li, Wei Wang, Minlan Zhang, Qi Chen, Fengyi Li, Shaojun Li · 2024 · BMC Endocrine Disorders
15. The brain-bone axis: investigating the interaction between the central nervous system and skeletal homeostasis
    Meng Yin, Haojun Shi, Cui Lv, Liang Shi, Liang Xie, Gongchang Yu, Kai Xu · 2025 · Medicine Plus
16. Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stages
    Manuela Dicarlo, Patrizia Pignataro, Daniele Urso, Chiara Zecca, Maria Teresa Dell’Abate, Francesco Borlizzi, Valentina Gnoni, Alessia Giugno, Angela Oranger, Graziana Colaianni et al. · 2026 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
17. Associations of serum sclerostin levels with body composition, pulmonary function, and exacerbations in COPD patients
    Carlos Antonio Amado Diago, María Teresa García‐Unzueta, Juan Agüero Calvo, Paula Martín-Audera, Pablo Ramón Fueyo, Bernardo Alio Lavín, A.R. Guerra, Pedro Muñoz, Sandra Tello, A Berja et al. · 2022 · Pulmonology
18. Characterization of sclerostin’s response within white adipose tissue to an obesogenic diet at rest and in response to acute exercise in male mice
    Nigel Kurgan, Bradley J. Baranowski, Joshua Stoikos, Adam J. MacNeil, Val Andrew Fajardo, Rebecca E. K. MacPherson, Panagiota Klentrou · 2023 · Frontiers in Physiology
19. Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria
    Daniel Rodríguez, Ekaterina Gurevich, Soroush Mohammadi Jouabadi, Eva Maria Pastor Arroyo, Alexander Ritter, Sandrine Estoppey Younes, Carsten Alexander Wagner, Pedro Henrique Imenez Silva, Harald Seeger, Nilufar Mohebbi · 2023 · Clinical Kidney Journal
20. Serum level of sclerostin and vitamin D in children with epilepsy
    Abdalla Al-Ma’moon Sarhan, Wael Mahmoud, Munayr Jabullah Aldarah, Noha Ali Hashim · 2024 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
21. Sclerostin and Adipose Tissue
    Keertik S. Fulzele, Paola Divieti Pajevic · 2017 · Current Molecular Biology Reports
22. Sclerostin Modulation Holds Promise for Dental Indications
    Mohamed G. Hassan, Abbas Rafik Zaher, Juan Martín Palomo, Leena Palomo · 2018 · Healthcare
23. Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis
    Alice Wang, Nishi Karunasinghe, Lindsay Dudley Plank, Shuotun Zhu, Sue Osborne, Charis Brown, Karen Suzanne Bishop, Tiffany Schwass, Sofian Tijono, Michael Holmes et al. · 2021 · Scientific Reports
24. POLİKİSTİK OVER SENDROMLU HASTALARDA SERUM SKLEROSTİN VE DİCKKOPF-1 SEVİYELERİ
    Ogün Bilen, Yıldız Garip Bilen, Mustafa Eroğlu, Hakan Türkön, Yasemin Şefika Akdeniz, Mehmet Aşık · 2022 · Kocatepe tıp dergisi.
25. Utilization and Reference Values of Bone Turnover Markers: Osteocalcin and Procollagen Type 1 N-Propeptide
    Milan Bayer, Vladimír Palička · 2017 · Biomarkers in disease
26. Effects of progesterone therapy on serum sclerostin levels in healthy menopausal women: a 3-month randomized, placebo-controlled clinical trial
    Yuzhou Yang, Azita Goshtasebi, Antoon H van Lierop, Dharani Kalidasan, C. L. Hitchcock, Jerilynn C. Prior · 2020 · Osteoporosis International
27. The Relationship between Serum Sclerostin Levels and Bone Mineral Disorders and Vascular Calcification in Hemodialysis Patients
    Emad Ali Abdallah, Nevine Sherif, Osama Mosbah, Amna Ahmed Metwaly, Ibrahim M. Abd ElAzim, Ola Mahmoud, Mohamed Farouk, Samah Mamdouh, Samya El-Shishtawy, Asmaa Hamdi Mohamed · 2021 · Open Access Macedonian Journal of Medical Sciences
28. Association Between Sclerostin and Sarcopenia-Related Functional Decline in Older Women
    Dong Gyu Lee, Jong Ho Lee, Eunjung Kong · 2026 · Diagnostics
29. Bariatric Surgery and Metabolic Bone Disease: Crosstalk between Muscle, Adipose Tissue, and Bone
    Leandro Silva Borges, Andréa Beatriz Gonçalves Bezerra, Giorjines Boppre, Elaine Hatanaka, Hélder Fonseca · 2026 · Obesity Surgery
30. Combined effects of a low-dose multi-target supplement (CaHMB, CBP, and HA) on delaying musculoskeletal aging
    Haoqi Chen, Junhong Peng, Shanshan Guo, Ting Chen, Si Chen, Xinyuan Jin, Wenge Huang, Chao Xu, Mengchu Li, Mengxing Xie et al. · 2026 · Food & Function
31. Effect of belt electrode-skeletal muscle electrical stimulation on fracture healing in a rat femoral fracture model
    Yuta Tsubouchi, Takashi Kataoka, Ryota Takase, Takefumi Otsu, Ryoji Hamanaka, Masashi Kataoka, Nobuhiro Kaku · 2026 · BMC Musculoskeletal Disorders
32. Sex-specific changes in metabolic and musculoskeletal biomarkers after acute resistance exercise in healthy young adults
    Kristen J. Koltun, Adam J. Sterczala, Varun J. Patel, Jennifer N. Forse, Kellen T. Krajewski, Nicole M. Sekel, Mita T. Lovalekar, Brian J. Martin, Christopher Connaboy, Thomas J. O’Leary et al. · 2026 · Applied Physiology, Nutrition, and Metabolism
33. Acute Modulation of Circulating Exerkines Responses to a Circuit and Traditional Resistance Training in Young Adults: A Pilot Study
    Pragya Sharma Ghimire, Adam C. Eckart, Madhumitha Sadhasivan Gayathri, Michelle Manochio · 2026 · Biomolecules
34. Variables que influyen en las concentraciones de esclerostina en los pacientes con diabetes mellitus tipo 2 y su asociación con el metabolismo óseo
    Antonia García‐Martin, Rebeca Reyes‐García, Pedro Rozas-Moreno, Mariela Varsavsky, Inés Luque-Fernández, MD Avilés-Pérez, Manuel Muñoz‐Torres · 2012 · DOAJ (DOAJ: Directory of Open Access Journals)
35. Serum Sclerostin as Biomarker in Osteogenesis Imperfecta
    Roland Kocijan, Sebastian Dinu, Christian Muschitz · 2015 · Exposure and Health
36. The temporospatial pattern of energy metabolism coordinates the interactions between the bones and other organ systems
    Ziyi Wang, Hiroshi Kamioka · 2017 · Journal of Oral Biosciences
37. Serum Sclerostin as Biomarker in Osteogenesis Imperfecta
    Roland Kocijan, Sebastian Dinu, Christian Muschitz · 2017 · Biomarkers in disease
38. Role of WNT signaling morphogenic proteins (sclerostin and β-catenin) in adipogenesis
    Anastasiia S. Kulakova, Irina A. Snimshchikova, Maria O. Plotnikova · 2020 · Russian Journal of Immunology
39. Effects of running a marathon on sclerostin and parathyroid hormone concentration in males aged over 50
    Aleksandra Zagrodna, Anna Książek, Małgorzata Renata Słowińska-Lisowska, Jan Chmura, Piotr P. Ponikowski, Giovanni Lombardi · 2023 · Journal of Sports Sciences
40. Association Between Plasma Sclerostin Levels and Body Mass Index in Women With Polycystic Ovary Syndrome
    Mete Bertizlioğlu, Ayşe Gül Kebapçılar, Levent Kebapçılar, Fıkret Akyürek, Zekiye Soykan Sert, Çetın Çelık · 2023 · Cureus
41. Emerging roles of osteocytes in the regulation of bone and skeletal muscle mass
    Md. Rameez Moin, Shubhrajyoti Das, Sabyasachi Sanyal · 2024 · Journal of Molecular Endocrinology
42. Bone mineral density and serum sclerostin levels in early ankylosing spondylitis: their possible correlation with a panel of disease activity and structural change parameters
    Manal Aly Abdel Khalek, Wael A. M. Nassar, Alyaa Ahmed El-Sherbeny, Raafat T. Escandar · 2013 · Egyptian Rheumatology and Rehabilitation
43. Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults
    C.M. Jankowski · 2012 · Yearbook of Sports Medicine
44. Diabetes Mellitus and Bone Disorders
    Mabel Yau, Cemre Robinson, Mark A. Sperling · 2020 · Elsevier eBooks
45. Fisiología del hueso y marcadores bioquímicos del recambio óseo
    Amparo Calleja Canelas, Nerea Varo Cenarruzabeitia, Eider Pascual Corrales · 2014 · Elsevier eBooks
46. Antikörpertherapie in der Osteologie
    Roland Kocijan · 2015 · Journal für Kardiologie (Krause & Pachernegg GmbH)
47. Sclerostin: A Novel Key to Bone and Dental Treatment
    Carlo · 2012 · Current Research in Dentistry
48. Osteocytes, bone remodeling and parathyroid hormone
    Nabanita S. Datta · 2012 · Endocrinology Studies
49. Variables which influence concentrations of sclerostin in patients with diabetes mellitus type 2 and its association with bone metabolism
    Antonia García‐Martin, Rebeca Reyes‐García, Pedro Rozas-Moreno, Mariela Varsavsky, Inés Luque-Fernández, MD Avilés-Pérez, Manuel Muñoz‐Torres · 2012
50. Zukünftige Osteoporosemedikamente
    Roland Kocijan, Heinrich Resch · 2013 · rheuma plus
51. Reply
    Anja Rabenhorst, Karin Hartmann · 2014 · Journal of Allergy and Clinical Immunology
52. Sclerostin : a key regulator of bone metabolism
    Antoon H van Lierop, van · 2013 · Leiden Repository (Leiden University)
53. Concentrations sériques de DKK-1, sclérostine et VEGF chez les patients atteints de spondylarthrite ankylosante et liens avec le tabagisme et les paramètres cliniques, inflammatoires et radiographiques
    Grigorios Theocharis Sakellariou, Alexios Iliopoulos, Maria Anna Polyzou Konsta, Eustathios I. Kenanidis, Michael E. Potoupnis, Eleftherios E. Tsiridis, Elpida Gavana, Fares E. Sayegh · 2017 · Revue du Rhumatisme
54. The effects of B cell depletion on bone turnover in rheumatoid arthritis
    Gillian Wheater · 2017
55. Basic Aspects of Osteocyte Function
    Jesús Delgado‐Calle, Teresita Bellido · 2020 · Contemporary Endocrinology
56. 各種調味料のレトルト加熱食品への利用--加熱耐性を有する調味料の応用例について (特集 レトルト食品の製造技術)
    素央 黒田 · 2000 · ジャパンフ-ドサイエンス
57. ASSESSMENT OF SERUM SCLEROSTIN LEVEL AS A BIOMARKER ASSOCIATED WITH BONE DISORDERS IN Β-THALASSEMIA PATIENTS IN AL- NAJAF CITY, IRAQ
    SHARBA Intisar Razzaq, Al-Dujaili Arshad Noori · 2021 · Southern Brazilian Journal of Chemistry
58. Bone and Metabolic Control
    Alexandre Chamouni, Franck Oury · 2019 · Elsevier eBooks
59. Utilization and Reference Values of Bone Turnover Markers: Osteocalcin and Procollagen Type 1 N-Propeptide
    Milan Bayer, Vladimír Palička · 2016 · Exposure and Health
60. Effect of a 3-month L-carnitine supplementation and resistance training program on circulating markers and bone mineral density in postmenopausal women: a randomized controlled trial
    Robert Antoni Olek, Emilia Samborowska, Piotr Wiśniewski, Pawel Wojtkiewicz, Krystian Wochna, Jacek Zieliński · 2022 · Research Square
61. Effect of a 3-month L-carnitine supplementation and resistance training program on circulating markers and bone mineral density in postmenopausal women: a randomized controlled trial
    Robert Antoni Olek, Emilia Samborowska, Piotr Wiśniewski, Pawel Wojtkiewicz, Krystian Wochna, Jacek Zieliński · 2022 · Research Square
62. Regulation of Wnt Signaling Pathway by Costic Acid Derivative, An Efficient Strategy for Treatment of Glucocorticoid‐Induced Osteoporosis in Rat Model
    Xue Ru Jiang, Xiangying Kong · 2023 · ChemistrySelect
63. Assessment of serum Sclerostin level and its relationship to coronary calcifications in chronic kidney disease patients
    Tarek Zakaria El Baz, Ahmed Alaa-Eldin Ahmed Saad, Emam Mohammed AbdElaziz Emam, Nagwa A. G. Mohammed, Essam Yahya Ali Omar · 2023 · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal
64. Sclerostin - The silent bone breaker
    Kandasamy Roshni, Neetha J. Shetty, Deepa G Kamath · 2023 · Cumhuriyet Dental Journal
65. Bone glycolysis and the regulation of energy balance
    Hélder Fonseca · 2023 · Elsevier eBooks
66. Association of Lower Serum Sclerostin Levels With Elevated Risk for Increased Arterial Stiffness: The JPOS Cohort Study
    Junko Tamaki, Takahiro Tachiki, Myadagmaa Jaalkhorol, Namiraa Dongmei, Misa Komastu, Kouji Tsuda, Asako Kudo, Kuniyasu Kamiya, Katsuyasu Kouda, Etsuko Kajita et al. · 2024 · The Journal of Clinical Endocrinology & Metabolism
67. The Association of Bone-related Biomarkers With Incident Hip Fracture: A Nested Case-control Study
    SARA JANE CROMER, Elaine Wei-Yin Yu, Elisabetta Patorno, Gary C. Curhan, Julie M. Paik · 2025 · Journal of the Endocrine Society
68. Observational and Mendelian randomization studies of plasma sclerostin levels do not provide evidence of cardiovascular adverse effects of sclerostin inhibition
    Rósa B. Þórólfsdóttir, Garðar Sveinbjörnsson, Grímur Hjörleifsson Eldjárn, Hildur M. Aegisdottir, Unnur Styrkársdóttir, Sólveig Grétarsdóttir, Valgerður Steinthórsdóttir, Vinicius Tragante, Ásmundur Oddsson, Lilja Stefánsdóttir et al. · 2025 · Human Molecular Genetics
69. Correlation of Sclerostin Serum Levels with the Pathogenesis of Coronary Artery Disease
    Shahlaa Shafiq Rozoqi, Thikra Ali Allwsh · 2025 · Advanced Biomedical Research
70. Additional file 1 of Effect of a 3-month L-carnitine supplementation and resistance training program on circulating markers and bone mineral density in postmenopausal women: a randomized controlled trial
    Robert Olek, Samborowska, Emilia, Wisniewski, Piotr, Pawel Wojtkiewicz, Krystian Wochna, Jacek Zieliński · 2023 · Figshare
71. Additional file 2 of Deciphering the potential pharmaceutical mechanism of Guzhi Zengsheng Zhitongwan on rat bone and kidney based on the “kidney governing bone” theory
    Yao, Baojin, Liu, Jia, Zhang, Mei, Leng, Xiangyang, Daqing Zhao · 2020 · Figshare
72. Additional file 1 of Deciphering the potential pharmaceutical mechanism of Guzhi Zengsheng Zhitongwan on rat bone and kidney based on the “kidney governing bone” theory
    Yao, Baojin, Liu, Jia, Zhang, Mei, Leng, Xiangyang, Daqing Zhao · 2020 · Figshare
73. Additional file 3 of Deciphering the potential pharmaceutical mechanism of Guzhi Zengsheng Zhitongwan on rat bone and kidney based on the “kidney governing bone” theory
    Yao, Baojin, Liu, Jia, Zhang, Mei, Leng, Xiangyang, Daqing Zhao · 2020 · Figshare
74. Sclerostin as a modern marker of bone-mineral disorders associated with chronic kidney disease in patients with chronic kidney disease stage V and diabetes mellitus
    T.L. Malska, Liliya Martynyuk · 2026 · The Journal of V N Karazin Kharkiv National University series Medicine
75. Biomaterials at the interface of bone-derived factors and inter-organ communication: Current evidence and future perspectives
    Luli Ji, Fuwei Zhu, Xiaogang Wang, Jing Wang, Changsheng Liu · 2026 · Bioactive Materials
76. Osteoglycin and Sclerostin Imbalance in Hypophosphatasia: Bone-Derived Markers of Mineralization and Systemic Involvement
    Luis Martínez-Heredia, Clara Toro-Comino, María José Muñoz-Domene, María Trinidad González Cejudo, María Carmen Andreo-López, Victoria Contreras-Bolívar, Cristina García‐Fontana, Beatriz García-Fontana, Manuel Muñoz‐Torres · 2026 · International Journal of Molecular Sciences
77. A novel platform incorporating multiple forms of communication to support applications in a mobile environment
    James Elton · 2014 · Loughborough University Institutional Repository (Loughborough University)